QCM
HBIO icon

Quaker Capital Management’s Harvard Bioscience HBIO Stock Holding History

Quaker Capital Management’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,535
Closed -$126K – 44
2013
Q2 		$126K Buy
+3,535
New +$135K 0.01% 43

Other funds holding HBIO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Quaker Capital Management's HBIO Position: Q3 2013 in Review

Quaker Capital Management sold out of Harvard Bioscience (HBIO) in Q3 2013, closing a stake of 3,535 shares — an estimated $126K sold.

Quaker Capital Management first reported a position in HBIO in Q2 2013 and held it in 1 quarter. The position peaked at $126K in Q2 2013. 81 funds tracked by Wall St. Rank hold HBIO as of Q3 2013.

  • Quaker Capital Management reported no remaining Harvard Bioscience position as of Q3 2013 after selling out during the quarter.
  • Quaker Capital Management sold 3,535 Harvard Bioscience shares in Q3 2013, an estimated $126K.
  • Quaker Capital Management first reported a position in Harvard Bioscience in Q2 2013 and held it in 1 quarter.
  • Quaker Capital Management's Harvard Bioscience position peaked at $126K in Q2 2013.
  • 81 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2013.

Based on Quaker Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.